Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

Author: Pharma and BioTech News April 24, 2026 Duration: 5:15
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Regeneron has recently achieved a pivotal milestone with the FDA's approval of its hearing loss gene therapy, Otarmeni. This approval, facilitated through the FDA’s Commissioner's National Priority Voucher Program, emphasizes the expanding recognition of gene therapies as essential therapeutic modalities. Otarmeni stands out as it directly targets an underlying...

Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: en-us Episodes: 65

Pharma and BioTech Daily
Podcast Episodes
Kailera IPO Raises $625M for Obesity Drug | Pharma and Biotech Daily [not-audio_url] [/not-audio_url]

Duration: 5:19
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore China's burgeoning role in the synthetic biology sector, as outlined…
Gene Therapy Setbacks and Strategic Shifts in Biotech [not-audio_url] [/not-audio_url]

Duration: 4:49
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. This week, we delve into a series of compelling stories that are shaping the future of…
AI Integration and Regulatory Shifts in Pharma [not-audio_url] [/not-audio_url]

Duration: 6:03
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're exploring a fascinating realm where technology and biology converge, start…
Radiopharmaceuticals to CAR-T: Pharma's Cutting-Edge Advances [not-audio_url] [/not-audio_url]

Duration: 5:10
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most intriguing advancements and strategic moves shapi…
Biopunk Revolution: Reshaping Biotech Innovation [not-audio_url] [/not-audio_url]

Duration: 5:23
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the transformative potential of biopunk and community labs tha…
Revolutionizing Pharma: Key Innovations and Strategic Shifts [not-audio_url] [/not-audio_url]

Duration: 4:50
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of exciting and transformative updates shaping our in…